is one of the leading research-driven biopharmaceutical companies to span the entire value chain of a medicine from discovery, early- and late-stage development to manufacturing and distribution, and the global commercialisation of primary care and specialty care medicines that transform lives. AZ employs around 51,500 peoples worldwide and operates in more than 100 countries. The Mölndal R&D site is one of the major AZ research centres. The Cardiovascular and Metabolic Disease iMED unit and Respiratory, Inflammation and Autoimmune iMED unit are co-located at Mölndal site. The computational chemistry group in Discovery Sciences, Mölndal provides computational chemistry support for both in-house lead generation/optimization projects and drug discovery projects with external partners. It has the state-of-the-art computational tools and high performance computing hardware. We work in an interdisciplinary environment by closely interacting with experts from high throughput screening, medicinal chemistry, X-ray structure solving and NMR analysis. We also have extensive experience in working on EU and Swedish government funding project, such as IMI European lead factory project, OpenPhacts, FP7-Mediplant, H2020-ExCAPE, BIGCHEM, etc.